Click here to take the CME Evaluation and Post-Meeting Survey
Dr. Jane R. Zucker has served as the Assistant Commissioner for the Bureau of Immunization at the New York City Department of Health and Mental Hygiene since August 2005. Her responsibilities include development of programs and policies to increase vaccine coverage of adults, adolescents and children citywide, introduction of new vaccines, and oversight of the Vaccines for Children program (VFC) and the Citywide Immunization Registry (CIR). Under her leadership, vaccination coverage for routinely recommended vaccines across the lifespan have increased. She is currently serving as the Director of the Vaccine Operations Center for the NYC Health Department’s COVID’s response having led efforts to increase flu vaccination last fall and now COVID-19 vaccination.
Her experience includes working on tetanus and anthrax vaccination after 9/11, smallpox vaccination for health care workers in the early 2000s, H1N1 vaccination during 2009-2010, Ebola vaccination in 2016 and 2017 in Sierra Leone with CDC and serving in a leadership role guiding New York’s City’s response to the 2018-2019 measles outbreak.
Dr. Zucker started with the CDC in 1990 as an Epidemic Intelligence Service Officer in the Malaria Branch, Division of Parasitic Diseases. In 1996, she was assigned to the United Nations Children's Fund (UNICEF) to oversee their global polio eradication initiative. She joined the Bureau of Immunization as Medical Director in 2000.
Dr. Zucker received her MD degree from the Mount Sinai School of Medicine and her MSc degree in Epidemiology from the Harvard School of Public Health. She completed her internal medicine residency at Kings County Hospital/SUNY Downstate and her Infectious Diseases fellowship at the Beth Israel, Brigham and Women's Hospital and Dana Farber Cancer Institute program in Boston. Dr. Zucker is board certified in internal medicine and infection diseases and is a Fellow in the Infectious Disease Society of America. She is widely published in peer-reviewed medical journals.
At the completion of this educational session, participants will:
1. Appreciate the epidemiology of vaccine-preventable infections in NYC, and the role that immunizations play in reducing their impact.
2. Know the current recommendations for vaccines in at-risk adolescent and adult HIV-positive patients and PrEP candidates, including recent updates to meningococcal, hepatitis A, HPV and pneumococcal vaccine recommendations.
3. Know evidence-based strategies for increasing practice-level vaccination coverage rates.
This CME activity has approved for AMA PRA Category 1.0 Credit™
for September 14, 2022, as a live activity.
This activity will also be available as an enduring activity from September 15, 2022, through September 13, 2025.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to one (1.0) Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. Braun (Course Director) has no relevant financial relationships to disclose.
- Dr. Valenti (Moderator/Panelist) has no relevant financial relationships to disclose.
- Dr. Jane R. Zucker (Presenter) has no relevant financial relationships to disclose. Dr. Zucker will submit their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature.
- Dr. Tristan D. McPherson (Panelist) has no relevant financial relationships to disclose. Dr. McPherson will submit their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation